Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
52 studies found for:    " June 01, 2011":" July 01, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Download search resultsDownload the search results for:
" June 01, 2011":" July 01, 2011"[FIRST-RECEIVED-DATE]AND HIV[CONDITION] (52 records)
Download Content:
zip file readers with free trial periods: WinZip and PKZip
Rank Status Study
1 Completed HIV Diagnosis in Hospitalized Malawian Infants
Condition: HIV Infections
Intervention: Device: Point of care HIV RNA PCR
2 Unknown  Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
Condition: HIV Positive
Intervention: Drug: Vorinostat
3 Completed Non-interventional Study on Use of Darunavir With Ritonavir in Clinical Practice
Condition: HIV Infections
Intervention: Drug: darunavir/ritonavir plus background regimen
4 Terminated Switch to Darunavir/r + Maraviroc Quaque Die in Patients With R5 Tropism by Viral DNA Genotyping (GUSTA)
Condition: HIV Infection
Interventions: Drug: Maraviroc, Darunavir/r;   Drug: current antiretroviral therapy with 3 drugs
5 Completed Residual Risk Assessment Of HIV Transmission
Condition: HIV Infection
Intervention: Biological: blood and semen sampling, specific biological exams and biobank and self administered questionnaires
6 Completed Evaluating the Safety and Immune Response to an HIV Vaccine in Healthy, HIV-Uninfected Adults Who Have Participated in Previous HIV Vaccine Clinical Trials and in Adults Who Have Not Participated in Previous HIV Vaccine Clinical Trials
Condition: HIV Infections
Interventions: Biological: Sub C gp140 Vaccine;   Biological: MF59C.1 Adjuvant
7 Completed
Has Results
Effect of Multiple Dosing With BI 201335 on the Pharmacokinetics of Darunavir Co-administered With Ritonavir in Healthy Male and Female Volunteers
Condition: HIV Infections
Interventions: Drug: Darunavir;   Drug: Ritonavir;   Drug: BI 201335
8 Completed Safety and Tolerability of Crofelemer for HIV-Associated Diarrhea
Conditions: HIV Enteropathy;   Diarrhea With HIV
Intervention: Drug: Crofelemer
9 Completed Therapy to Elevate CD4 Counts in HIV-1 Disease
Condition: HIV Disease
Intervention: Biological: alpha-1-Proteinase Inhibitor
10 Active, not recruiting
Has Results
REMEMBER: Reducing Early Mortality & Morbidity by Empiric Tuberculosis (TB) Treatment
Condition: HIV Infection
Interventions: Drug: Atripla (r);   Drug: Efavirenz;   Drug: Truvada;   Drug: Rifampin/isoniazid/pyrazinamide/ethambutol FDC;   Drug: Rifampin/isoniazid FDC;   Drug: Isoniazid
11 Completed Vitamin D HIV Study
Condition: HIV
Interventions: Drug: Vitamin D3;   Drug: Placebo
12 Completed
Has Results
A Clinical Trial Comparing the Efficacy of Darunavir/Ritonavir Monotherapy Versus a Triple Combination Therapy Containing Darunavir/Ritonavir and 2 Nucleoside/Nucleotide Reverse Transcriptase Inhibitors in Patients With Undetectable Plasma HIV-1 RNA on Current Treatment
Conditions: Human Immunodeficiency Virus (HIV) Infections;   Acquired Immunodeficiency Syndrome (AIDS) Virus
Interventions: Drug: Darunavir;   Drug: Ritonavir
13 Completed Genetics and HIV-1 Protease Inhibitors
Condition: HIV
Intervention: Drug: Atazanavir
14 Completed Safety and Effectiveness of Tenofovir Gel in the Prevention of Human Immunodeficiency Virus (HIV-1) Infection in Women and the Effects of Tenofovir Gel on the Incidence of Herpes Simplex Virus (HSV-2) Infection
Condition: HIV Prevention
Interventions: Drug: Tenofovir gel;   Drug: Universal placebo gel
15 Completed Genotypic Tropism Testing In Proviral Dna To Guide CCR5 Antagonist Treatment In Subjects With Undetectable HIV-1 Viremia
Condition: HIV
Intervention: Drug: Unique
16 Completed Urban Health Study II
Condition: HIV
Interventions: Behavioral: Standard Referral;   Behavioral: Project Bridge
17 Completed A Parenting and Self-Care Intervention for HIV Infected Mothers
Condition: HIV
Intervention: Behavioral: IMAGE Intervention
18 Completed The PeerCARE Study (Peer Community-based Assistant in REtention)
Condition: HIV
Intervention: Behavioral: Peer Support
19 Completed Feasibility of a Stigma Reduction Intervention for Human Immunodeficiency Virus (HIV)-Infected Women
Conditions: Human Immunodeficiency Virus (HIV);   Self-efficacy;   Self-esteem
Intervention: Behavioral: Ipod video
20 Completed Relative Bioavailability Study of a Pediatric Granule Formulation of Dolutegravir
Condition: Infections, Human Immunodeficiency Virus and Herpesviridae
Interventions: Drug: Dolutegravir 50 mg tablet;   Drug: Dolutegravir 50 mg oral granules

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.